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Background. Cluster randomized trials have been utilized to evaluate the effectiveness of
HIV prevention strategies when the study endpoint is population-level incidence (Hughes
and Kulich 2006). Design of such studies must take into account possible correlation of
outcomes within randomized units.
Purpose. This paper discusses the power and sample size considerations for cluster ran-
domized trials of combination HIV prevention, using a proposed HIV prevention study in
Botswana as an illustration.
Methods. We introduce a new agent-based simulation model to evaluate the impact of com-
bination prevention strategy at a community level and investigate how correlation structure
within a community affects the coefficient of variation–an essential parameter in designing a
cluster randomized trial.
Results. We constructed collections of sexual networks and then propagated HIV on these
networks to simulate the disease epidemic. Increasing level of sexual mixing between inter-
vention and standard-of-care communities reduces the difference in cumulative incidence in
the two sets of communities. Fifteen clusters per arm and 500 incidence cohort members
per community provides 96% power to detect the projected difference in cumulative HIV
incidence between SOC and intervention communities (3.82% and 2.24%) at the end of the
third study year, using the model-based projected value of coefficient of variation 0.24. Al-
though available formulas for calculating sample size can be derived from random effects
models in which cluster-level random effects are assumed to be independent across clusters,
as are individual outcomes within clusters (e.g., an exchangeable correlation structure), we
show that deviations from an exchangeable correlation assumption do not generally affect
the validity of such formulas.
Limitations. We construct our sexual network based on data from Likoma island, Malawi
and base disease progression on longitudinal estimates from an incidence cohort in Botswana
and in Durban as well as a household survey in Mochudi, Botswana. It would be desirable
to have alternative network data and more precise estimates based on larger sample sizes for
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disease progression to assess the robustness of our model results.
Conclusions. Epidemic modeling plays a critical role in planning and evaluating treatment
for prevention. Simulation studies allow us to take into consideration available information
on sexual network characteristics, such as mixing within and between communities, as well
as coverage levels for different prevention modalities in the combination prevention package
under study.
Keywords: cluster randomized trials; network models; design effect; HIV prevention
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Background
Many HIV transmission prevention approaches have been demonstrated to be effective when
studied separately in individual-level clinical trials, and efforts are now underway to in-
vestigate whether combining these modalities can achieve community-level control of HIV
infection (Boily et al., 2012). The prevention modes thus far demonstrated to be effica-
cious include antiretroviral treatment as prevention (TasP), male circumcision (MC), pre-
exposure prophylaxis (PrEP) (in some populations) and preventing mother-to-child trans-
mission (PMTCT). The underlying rationale for TasP is the increase in risk of HIV transmis-
sion with increases in viral load. Quinn et al. (2000) estimated that each ten-fold increment
in viral load is associated with a 2.45-fold increase in the risk of HIV transmission per sexual
contact. Gray et al. (2001) reported that the transmission rate per couple increased from
1/43 to 11/45 comparing subjects with viral load < 1700 copies/ml to those with viral load
between 1, 700 copies/ml to 12, 400 copies/ml.
Incidence of infection depends on factors operating both at the individual subject level, such
as risk behavior, and at the community level, such as sexual network characteristics, i.e., the
risk behavior of an individual’s partner affects the individual’s risk. Nonetheless, prevention
strategies target individual-subject characteristics, like viral load of infected partners, to
reduce transmission efficiency per sexual act have the potential for significant reductions in
incidence (Granich et al., 2009). A meta-analysis based on 5021 heterosexual couples from
11 cohorts reported a 92% reduction in heterosexual transmission rates comparing patients
on ART to those not on ART, and no transmission events were observed in discordant het-
erosexual couples if the HIV-infected partner was treated with ART and had a viral load
below 400 copies/ml (Attia et al., 2009). Recently, a randomized clinical trial conducted by
HIV Prevention Trials Network (HPTN Study 052) reported a 96% (95% CI) reduction in
HIV transmission in HIV-1 sero-discordant couples comparing immediate versus delayed use
of antiretroviral treatment by HIV-infected individuals with a CD4 cell count between 350-
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550 per cubic millimeter (cells/mm3) at enrollment and therefore did not require treatment
according to treatment guidelines (Cohen et al., 2011).
A modified treatment-for-prevention strategy, proposed by Novtisky et al. (2010), expands
treatment to individuals with high viral load, but who otherwise do not qualify for treat-
ment under the current guidelines. Previous studies (Novitsky et al. 2010, 2011) showed that
about 25% of new HIV-1C infections in southern Africa maintain high viral load levels for at
least 1-2 years; furthermore, those with higher viral load levels appeared to have a quicker
CD4 cell count decline. Identifying and treating this subset can lead to both individual ben-
efits, achieved by delaying onset of clinical AIDS, and public health benefits resulting from
reductions in HIV transmission (Novitsky and Essex 2012). These considerations have led
to interest in evaluating a combination prevention package that includes treatment of high
viral load carriers in a cluster-randomized trial in Botswana. Botswana is an appropriate
setting for this study, because it has one of the highest rates of HIV prevalence, estimated
at 24.8% of adults by UNAIDS in 2009. In addition, the country has had an active program
for ART treatment based on CD4 <350 cells/ml and/or AIDS-defining illness as well as high
uptakes for the PMTCT program. Rates of male circumcision (MC) have been estimated at
to be low (12-14%).
Cluster randomized trials are ideally suited to investigate both direct and indirect effects
of prevention interventions. Design of such studies must take into account possible corre-
lation of outcomes within randomized units, which induces between-community variation.
In this paper, we describe power and sample size considerations for cluster randomized tri-
als of combination HIV prevention, using the proposed Botswana study as an illustration.
We introduce a new agent-based simulation model to evaluate the impact of combination
prevention strategy at a community level and investigate how correlation structure within
a community may affect the coefficient of variation– an essential parameter in designing a
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cluster randomized trial.
Methods
Study design overview
The proposed study is intended to assess whether implementation of a combination of pre-
vention interventions can significantly reduce HIV incidence. Villages in Botswana will be
randomized into one of the two arms:
A) “standard of care” (SOC) with ART for HIV-infected individuals with CD4<350 cells/ml
or AIDS;
B) ART for HIV-infected individuals with CD4<350 cells/ml or AIDS, plus ART for those
with high viral load (>10,000 copies/ml), plus combination prevention: strategies of
enhanced HTC, PMTCT, enhanced test-linked care (TLC) in relation to ART initiation
and follow-up, and male circumcision.
Sampling strategy
The primary estimate of HIV incidence will be obtained from a cohort identified through a
random sample of 20% of households in each community. This cohort (designated incidence
cohort) will include all consenting eligible HIV-negative household members. Subjects in
the incidence cohort will be followed for 3 years and tested annually for HIV status. In es-
tablishing the percentage of households to be sampled, two factors were taken into account:
1) adequacy of power, and 2) minimizing home-based testing in the SOC communities. As
enhancing HIV testing is one of the interventions under study, home-based testing cover-
age in SOC communities will attenuate treatment differences between SOC and intervention
communities. We chose 20% based on the power it provides and on estimated treatment
effects that are described below.
Matching factors
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Because the number of randomized units in a cluster randomized trial is generally small
compared to that in a randomized trial of independent units, a pair-matched design helps to
ensure that the baseline community characteristics are similar for communities randomized
into the 2 arms. The communities can be paired based on similarities in population and
geographical location. In the Botswana study, the communities cannot be matched based
on their baseline incidence because accurate incidence estimates are not available for the
proposed study sites.
Sample size determination
Sample size was based on estimates of power to detect intervention effects calculated from
the following formula developed for matched cluster randomized trials (Hayes and Moulton
2009):
c = 2 + (zα/2 + zβ)
2pi0(1− pi0)/m+ pi1(1− pi1)/m+ k
2
m(pi
2
0 + pi
2
1)
(pi0 − pi1)2
,
where c is the number of clusters required per treatment arm, pi0 and pi1 are the true pro-
portions of who reach endpoint in the two treatment arms, respectively; m is the number of
individuals within each cluster, km is the coefficient of variation in true proportions between
clusters within matched pairs in the absence of intervention, and zα/2 and zβ are the usual
standard normal distribution values corresponding to upper tail probabilities of α/2 and β,
respectively. Although our endpoint will be interval-censored times to infection, we develop
power calculations for simplified binary outcomes. These should provide a reasonable ap-
proximation to power, but may be somewhat conservative as they do not make use of times
to event.
To predict the cumulative incidence over the study period in intervention and control commu-
nities, we used an agent-based epidemic simulation model, in which the HIV was propagated
on collections of generated sexual networks. Parameter values in the model were set based
on published literature as well as information from (1) the Mochudi study, a pilot study to
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evaluate the uptake of an HIV prevention program for the northeast sector of Mochudi, a
village in Botswana with a population of around 45,000 (Botswana Population and Housing
Census 2011); (2) the Botswana/Durban cohort, a cohort of acutely or recently infected
individuals combined from two southern African cohorts: the HIV pathogenesis Programme
Acute Infection Study in Durban, KwaZulu-Natal, South Africa (Wright et al., 2011), and
the Tshedimoso Study in Gaborone, Botswana (Novitsky et al., 2009; Novitsky et al., 2008;
Novitsky et al., 2011); and (3) the Likoma Island sexual network, a cross-sectional socio-
centric survey of sexual partnerships aiming to investigate the population-level structure of
sexual networks connecting the young adult population of several villages on Likoma Island,
Malawi (Helleringer and Kohler 2007).
Results
Generation of sexual networks.
In our models, sexual networks are represented as random graphs, in which each node rep-
resents an individual and each edge, a sexual relationship between the two individuals por-
trayed by the endpoints. These networks contain 2 types of nodes, male and female. The
networks are bipartite; that is, we only consider relationships between opposite genders,
reflecting the belief that the principal mode of transmission in Botswana is heterosexual
transmission (National AIDS Coordinating Agency, 2010). Furthermore, HIV transmission
from homosexual contact cannot be easily documented in Botswana. Each network repre-
sents all of the sexual relationships that occur in sets of matched pairs of communities during
the course of study. An illustrative network of 2 communities is provided in Figure 1.
[Figure 1 about here.]
In a sexual contact network, the number of edges adjacent to a particular node is called
its degree, and the degree distribution can be obtained by the collection of nodal degrees
(Wasserman and Faust 1994). We construct degree distributions from the reported number
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of sexual partners in four years from Likoma Island using a likelihood approach based on
the Yule distribution (Jones and Handcock 2003, Handcock et al., 2003).
Using the methods proposed in Goyal et al. (2011) that permit incorporation of user-specified
uncertainty associated with particular network properties, we generated networks that are
consistent with both a prescribed degree sequence and the target distribution for mixing
between a pair of communities. To understand the ramifications of mixing between commu-
nities on effect size, we considered a range of mixing values. The networks are generated
assuming random mixing by activity level, that is, the probability of forming a partnership
does not depend on the number of partnerships an individual has. For each relationship,
a date is drawn from a uniform distribution on the interval from start to end of study.
The date is randomly chosen to represent the start or end of the relationship to avoid time
trends in the number of relationships. The relationship duration is drawn from a duration
distribution estimated from self-reported data in the Mochudi study. For relationships with
durations longer than the study period, we calculate the likelihood of such relationships
presenting during the entire study period based on the study duration and the relationship
duration, and then adjusting either the start or end time to allow the possibility of such
events accordingly. A histogram of the partnership durations is given in Figure 2.
[Figure 2 about here.]
Simulate the disease epidemic
In addition to data from the Mochudi study and the Botswana/Durban cohort, our model
takes into account community characteristics including population size, varying coverage
levels for different prevention modalities, as well as individual characteristics including trans-
mission risk, disease progression, condom use, linkage to care, and circumcision status.
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At time study time 0, we set the initial condition for each community. Each eligible individ-
ual is assigned an initial HIV infection status based on the current prevalence in Botswana,
estimated to be 24.8%. Each infected individual is assigned to a viral load category as well as
an initial CD4 count based on estimates of their distributions from the household survey in
Mochudi. For CD4 counts below threshold for treatment, subjects are modeled as receiving
ART according to estimates from Mochudi. The percentage of condom use is set as 40%
and male circumcision rate at the start, at 12.7%, the estimated rate for Botswana(BAIS
2008). Background ART coverage for CD4<350 is set at 60.9% at the start based on a
recent survey of the Mochudi district in Botswana in 2011. The probability of transmitting
to a partner is based on the infected individual’s viral load category, awareness of infection
status, circumcision status, and treatment status, each of which is subject to change over
time. For example, as disease progress, a subject’s CD4 count may decrease to below thresh-
old for treatment guidelines and making the subject eligible for treatment. The disease can
only spread to a partner during the duration of the partnership. Disease progressions are
assumed to follow estimates based on the Botswana/Durban cohort. Transmission risks to
partners for different viral load categories are based on data reported in Quinn et al. (2000);
additional sensitivity analyses are performed using rates reported in Attia et al. (2009) and
Lingappa et al. (2010). Reductions in transmission risks associated with knowing infection
status and condom use are set as 30% and 85%. Reduction in HIV acquisition risks for
circumcision is set as 60%. To mimic the study design, we randomly pick 20% of popula-
tion in each community to form the incidence cohort. Subjects in the incidence cohort are
tested annually for HIV infection, and subjects outside of this cohort are tested with prob-
abilities set to be the specified coverage levels for testing. The rates for circumcision, HIV
testing and counseling and linkage to care (Table 1) are chosen to be the targeted levels for
the intervention communities and the current levels for the standard of care communities.
These coverage levels are allowed to vary yearly, therefore, the model allows assessment of
the impact of a slower-than-expected intervention roll-out. In the standard of care commu-
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nities, subjects become eligible for treatment based on national treatment guidelines; in the
intervention communities subjects identified as high viral load carriers (>10,000 copies/ml)
are also eligible for treatment.
[Table 1 about here.]
Effect of sexual mixing between communities
Sexual mixing between two communities arises when subjects in one community have part-
ners from a different community. Mixing between intervention and standard- of-care com-
munities would be expected to increase cumulative incidence in the former and decrease it
in the latter, thereby attenuating the intervention effect. Simulating sexual networks with
different levels of mixing permits assessment of the effect of mixing on treatment effect and
subsequently on power and sample size estimation. Figure 3 illustrates the impact of in-
creasing levels of mixing while holding other conditions fixed, the effect of which is to make
the more similar the cumulative incidences in two sets of communities. When the mixing
level reaches 50% – a level that implies that subjects are equally likely to have partners
within and outside of their community – the expected cumulative incidence rates becomes
very similar.
[Figure 3 about here.]
Self-reported data from the Mochudi study suggest that approximately 30% of partnerships
were formed outside of that community. Mixing between communities randomized to the
same intervention or between SOC communities and those not in the study does not atten-
uate intervention effects. Furthermore, many Mochudi residents work in the nearby capital
city Gaborone, the residence of a considerable number of outside partners; by contrast most
villages are relatively far from major urban centers. Therefore for our setting, we choose
a lower level of mixing, 20%, with standard error 2.5%. These choices imply that about
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95% of sampled values will be between 15% to 25%. Table 2 below presents the projected
cumulative HIV incidences in SOC and intervention communities over 4 years of follow-up.
[Table 2 about here.]
Coefficient of variation
In addition to intervention effect, sample size calculation for a cluster randomized trial
requires knowledge of coefficient of variation k, a parameter reflecting variations across com-
munities induced by correlations among study subjects within the same community. From
our simulations, we can obtain plausible values of k by dividing the sampling standard devi-
ation of the cumulative incidences for the standard-of-care communities from many repeated
experiments by their sample mean. In our model, all clusters are assumed to have the same
population sizes, initial conditions, and rates of disease progression for infected subjects.
These actually vary over communities, but because our study employs a matched-pair de-
sign, the appropriate k is the coefficient of variation in true proportion infected between
matched communities in the absence of intervention. Matched pairs are intended to be quite
similar in conditions, justifying the decision to keep them identical in simulations. Our simu-
lation study yielded a k about 0.24. As some heterogeneity is likely to be present even across
matched communities and has the effect of increasing k, we calculate power for values of k
ranging from 0.2 to 0.35. Figure 4 displays the number of clusters and cluster sizes needed
to achieve >90% power to detect the projected difference in 3-year cumulative incidences in
SOC communities and intervention communities.
[Figure 4 about here.]
Fifteen clusters per arm and 500 incidence cohort members per community yields 96% power
to detect the anticipated difference in cumulative HIV incidence between SOC and interven-
tion communities (3.82% vs. 2.24%) by the end of the third study year, for k = 0.24 and
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91% power for k = 0.30.
The sample size formula we used can be derived from random effects models in which cluster-
level random effects are assumed to be independent across clusters, as are individual out-
comes within clusters (e.g., an exchangeable correlation structure). We are concerned about
deviations from the exchangeable-correlation assumption because it is likely to be violated
for the outcome of HIV infection: for example, correlation between two individuals in a
partnership would be expected to be higher than that between two individuals who are far
apart in a sexual network but within a community. Fortunately, we found that deviations
from an exchangeable correlation assumption do not affect the validity of the sample size
formula. Under the exchangeable correlation structure, the intraclass correlation represents
correlation between any 2 subjects in the same cluster. When the exchangeable correla-
tion assumption is violated, the intraclass correlation ρ does not have this interpretation;
instead, it reflects average correlation of observations from the same cluster. Even with
arbitrary variance-covariance structure within cluster, however, the increase in variance re-
sulting from cluster sampling, commonly measured by the design effect (Kish 1965), can be
expressed by a function of the intraclass correlation ρ and the number of subjects within
cluster. The between-cluster coefficient of variation k – which provides equivalent informa-
tion regarding variance inflation as the intraclass correlation – captures the heterogeneity
in outcomes across clusters resulting from the correlations among subjects from the same
cluster.
To illustrate the assertions above, we consider the general setting where we have c clusters
and sample m subjects within each cluster. Let Yik represent the outcome of the k
th (k =
1, . . . , m) individual in ith (i = 1, . . . , c) cluster and we consider the following random effects
model with correlated error terms:
Yik = µ + αi + ik,
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where αi ∼ N(0, σ
2
BC), (i1, . . . , im)
T ∼ V = (σk,`), a variance-covariance matrix of dimen-
sion m. Let σ2WC = σkk and σ
2 = σ2BC + σ
2
WC denote the total variance. The correlation
matrix for the m subjects within the same community is:


1 ρ1,2 + ρC · · · ρ1,` + ρC · · · · · · ρ1,m + ρC
ρ2,1 + ρC 1 · · · ρ2,` + ρC · · · · · · ρ2,m + ρC
...
...
...
...
...
...
...
ρm−1,1 + ρC · · · · · · · · · · · · 1 ρm−1,m + ρC
ρm,1 + ρC · · · · · · · · · · · · ρm,m−1 + ρC 1


where ρC =
σ2BC
σ2
, ρk,` =
σk,`
σ2
.
The intraclass correlation ρ is defined as
E{(Yjk−µ)(Yj`−µ)}
E(Yik−µ)2
, where the expectation in the
numerator is over all distinct pairs of individuals (k 6= `) taken from the same cluster
and over all clusters and the expectation in the denominator is taken over all individuals
and all clusters. In our setting, ρ can be expressed as
σ2BC + {m(m− 1)}
−1
∑
1≤k 6=`≤m σk,`
σ2
.
The corresponding between-cluster variance σ2B = σ
2
BC + {m(m− 1)}
−1
∑
1≤k 6=`≤m σk,` and
the coefficient of variation
k =
σ2B
µ
=
σ2BC + {m(m− 1)}
−1
∑
1≤k 6=`≤m σk,`
µ
.
Following the similar derivations for the design effect under an exchangeable correlation
structure outlined in Hayes and Moulton (2009), it can be shown that the design effect
(DEFF ) in this case becomes:
DEFF = 1 + (m− 1)ρC +
∑
1≤k 6=`≤m ρk,`
m
= 1 + (m− 1)ρ.
To estimate between-cluster variance σ2B and coefficient of variance k, it is sufficient to use
summary measures from each cluster. Let Y i. denote the individual cluster means, Y .. denote
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the overall mean, and s2 denote the empirical variance of cluster means Y i., we can estimate
σ2B and k as follows:
σ̂2B = s
2 −
σ̂2WC
m
, and kˆ =
σ̂2B
Y ..
.
Table 3 presents the actual and estimated k, ρ, and DEFF under an arbitrary correlation
structure and illustrates that the design effect estimated based on intraclass correlation ρ
is unbiased. Here, we assume that there are 30 communities and each community has 20
individuals enrolled in the study. We let σWC = 1 and µ = 1. As σBC increases from 0 to 1,
the design effect increases from 1.5 to 10.8. The results are based on 1000 simulated studies.
Although the true correlation matrix within a cluster is arbitrary, a single parameter ρ is
sufficient to summarize the complex correlation structure and k captures the heterogeneity
in outcomes across clusters induced by the complex correlation structure.
[Table 3 about here.]
We note that when departure from exchangeable correlation structure is expected, it is im-
portant that the studies used to estimate k employ the same sampling strategy as will the
proposed study. Consider a special case where outcomes of individuals within the same
households are more correlated than those of individuals from different households within
the same community. Assume that the sampling strategy is such that within each of the c
clusters, we randomly sample a households and b subjects within each household.
Using the similar notation as before, the true data generating process can be expressed as:
Yijk = µ+ αi + γj + ijk,
where i = 1, . . . , c represents clusters, j = 1, . . . , a represents households, and k = 1, . . . , b
represents subjects. We assume that αi ∼ N(0, σ
2
BC), γj ∼ N(0, σ
2
BH), ijk ∼ N(0, σ
2
WH).
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Under this model,
var(Yijk) = σ
2
BC + σ
2
BH + σ
2
WH
∆
= σ2, cov(Yijk, Yijk′) = σ
2
BC + σ
2
BH, cov(Yijk, Yij′k′) = σ
2
BC.
Let ρH =
σ2BH
σ2
and ρC =
σ2BC
σ2
, the corresponding correlation matrix (ρk,`) within each cluster
is 

1 ρH + ρC · · · ρH + ρC ρC · · · ρC
ρH + ρC 1 · · · ρH + ρC ρC · · · ρC
...
...
...
...
...
...
...
ρC · · · ρC · · · · · · 1 ρH + ρC
ρC · · · ρC · · · · · · ρH + ρC 1


,
that is, ρk,` =


1 if k = `
ρC if k 6= `, and subjects k and ` are in different household
ρH + ρC if k 6= `, and subjects k and ` are in the same household
.
In the absence of household heterogeneity, σ2BH = 0 and ρH = 0, the correlation structure
would be exchangeable. The current model allows that subjects in the same households have
stronger correlation than subjects from different households in the same community.
The between-cluster variance σ2B = σ
2
BC +
b−1
ab−1
σ2BH. If we sample one person per household,
b = 1, then the coefficient of variation k1 =
σ2
BC
µ
; when we sample more than one people per
household, b > 1, k2 =
σ2BC+
b−1
ab−1
σ2BH
µ
, and k1 < k2 for any b > 1. Therefore, if the previous
study sampled one individual per household and the proposed study intended to sample
entire households, the estimated k from the previous study would underestimate the true
coefficient of variation for the proposed study and could result in an under-powered study.
Discussion
The properties of proposed study designed were investigated using simulation studies of epi-
demics propagated on collections of sexual networks. These studies allow us to take into
consideration some important sexual network characteristics, such as mixing within and
between communities, as well as coverage levels for different prevention modalities in the
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combination prevention package under study.
Matching of villages is most effective when based on accurate predictions of incidence in the
absence of intervention. Such predictions could be based on current estimates of incidence
– for example obtained from using cross-sectional methods that rely on an incidence assay
(e.g., the BED assay). In the proposed Botswana study, however, the anticipated number
of eligible subjects in each community is too small (only about 670 on average) for this
approach to be useful. Even based on optimistic assumptions (such as perfect assay speci-
ficity), only when the incidence rates for 2 communities differ greatly, say 1% versus 6-7%
or higher, would we be able to distinguish the difference from random variation. Such high
levels of incidence have not been observed in Botswana. Furthermore, use of assay-based
incidence estimates for matching would require the study team to wait until all or most of
the communities had completed the household surveys before any could be randomized and
study intervention could be initiated. This could delay the start of the study by almost a
year, it is preferable to randomize within pairs of communities and initiate the interventions
as soon as the household surveys are completed in both members of each pair.
Mathematical modeling plays a critical role in planning and evaluating treatment for pre-
vention (WHO report). As with any models, it is essential to understand the underlying
assumptions and the impact of different choices of input parameters (Goyal et al., 2012). We
construct our sexual network based on data from Likoma Island, and base disease progression
for incident cases and prevalent cases on longitudinal estimates from the Botswana/Durban
incidence cohort (n=77) and the Mochudi study. It would be desirable to have alternative
network data to assess the robustness of our model results, as well as precise estimates based
on larger sample sizes for disease progression. Nonetheless, our model estimates for the an-
nual and cumulative incidence rates of the SOC communities are in line with the projected
estimates from the UNAIDS Spectrummodel (http://www.unaids.org/en/dataanalysis/
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datatools/spectrumepp2013/). We also performed extensive sensitivity analyses for sce-
narios associated with lower-than-projected treatment effects (Figure 5). These analysis
demonstrated that, for the planned sample size and k of 0.24, the study has >80% power to
detect a reduction of 32% in the cumulative incidence in the intervention arm compared to
the SOC arm (3.82%).
[Figure 5 about here.]
The proposed Botswana study is one of the two large HIV prevention trials commissioned by
PEPFAR that are currently in development. The other is HPTN 071, the PopART study,
which investigates a combination of interventions including universal testing, counseling and
ART in Zambia and South Africa. The two trials differ in the components of combination
prevention. A special feature of the Botswana study is its focus on identifying high viral
carriers and treating them with ART. Both studies rely on extensive mathematical modeling
to investigate the plausibility of different effect sizes of intervention. These models make use
of information from a wide variety of sources regarding biology and behavior information
that will be updated during the course of the studies and at their completion.
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Figure 1. An illustrative example of a static network of 2 communities. Open circles and
solid circles represent individuals in different communities. Within each community, the
location of circles does not represent their geographical locations.
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Figure 2. Relationship Durations in Mochudi
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Figure 3. Cumulative incidence of intervention and standard-of-care communities over the
3-year period with varying levels of mixing
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Figure 4. Number of Clusters versus Cluster Size Needed to Ensure >90% Power to Detect
Anticipated Differences in Cumulative HIV Incidence Between SOC and Intervention Arms
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Figure 5. Power to detect various potential reductions in cumulative HIV incidence
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Table 1
Model input parameters to estimate impact of CP package scale-up in intervention
communities versus SOC communities over 4 years
SOC Arm Intervention Arm
HTC Male Circumcision Linkage to Care HTC Male Circumcision Linkage to Care
Baseline 37%1 12.7%1 80% 37% 12.7%1 90%
End Y1 37% 31.4%2 80% 81% 46.4%4 90%
End Y2 45% 50.0%2 80% 90%3 80%4 90%
End Y3 52% 60.0%2 80% 90%3 80%4 90%
End Y4 59% 70.0%2 80% 90%3 80%4 90%
1. BAIS 2008.
2. Male circumcision campaigns in SOC communities will be ongoing, and may reach 70% coverage
by the end of Y4 post randomization, if Ministry of Health targets are met.
3. Assume that the project aims to increase HTC coverage to ≥90% in intervention communities
by the end of the second study year and maintain this thereafter.
4. Assume that the project aims to reach 80% MC coverage in intervention communities by the
end of the second study year and maintain this thereafter.
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Table 2
Projected cumulative HIV incidence in SOC versus intervention communities over 4 years
of study follow-up
SOC Intervention
Cumulative Incidence Cumulative Incidence % Reduction
End of Y1 1.71% 1.26% 26.3%
End of Y2 2.90% 1.84% 36.7%
End of Y3 3.82% 2.24% 41.4%
End of Y4 4.51% 2.58% 42.9%
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Table 3
Actual and estimated coefficient of variation k, intraclass correlation ρ, and design effect.
Ê denotes average of estimates from 1000 simulated studies.
σBC ρ Ê(ρˆ) k Ê(kˆ) DEFF Ê( ̂DEFF )
0.0 0.027 0.028 0.164 0.153 1.512 1.522
0.1 0.037 0.036 0.192 0.181 1.695 1.687
0.2 0.064 0.064 0.259 0.253 2.223 2.220
0.3 0.107 0.108 0.342 0.339 3.039 3.049
0.4 0.161 0.158 0.432 0.426 4.062 4.007
0.5 0.222 0.219 0.526 0.525 5.210 5.170
0.6 0.285 0.286 0.622 0.635 6.406 6.437
0.7 0.347 0.341 0.719 0.713 7.592 7.478
0.8 0.407 0.409 0.817 0.835 8.727 8.780
0.9 0.462 0.461 0.915 0.929 9.786 9.766
1.0 0.513 0.514 1.013 1.052 10.756 10.759
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